RCT1_Header

Enrollment Planning and Patient Recruitment


Patient recruitment and up-front enrollment planning are critical to drug development programs. Patient recruitment if not adequately planned for can extend your development timeline by a number of years. Retention of patients throughout the life of a clinical trial is essential in order have complete data sets for your analysis and subsequent filings. In order to optimize both you have to have a plan. Cambridge Healthtech Institute’s Ninth Annual “Enrollment Planning and Patient Recruitment” conference will cover the topics one should consider when drafting and strategically implementing a patient recruitment plan for a clinical development program.

Stay on and attend Part 2: Engagement and Retention
Keynotes | Monday Short Courses | Speaker Biographies

Monday, February 22

Recommended Pre-Conference Short Course
2:00 pm - 5:30 pm

SC1: Implementing Social Media, Digital Marketing and Other New Strategies for Patient Recruitment*

*Separate registration required

Welcome and Networking Happy Hour on the Patio hosted by CHI, DrugDev and Praxis
7:00 pm - 9:00 pm

Tuesday, February 23 – Wednesday, February 24


OPENING PLENARY KEYNOTES
PATIENT-SITE-SPONSOR-COMMUNITY VOICES: ENGAGING THE CUSTOMER, BUILDING TRUST AND FURTHERING RESEARCH

Exploring the Need to Improve Clinical Trial Awareness  

Kelly McKee, Recruitment, Retention and Innovation Team Lead, Global Trial Optimization, Merck & Co., Inc.

ROI Expectations and Objectives for Optimized Patient Awareness and Engagement

Kenneth Getz, MBA, Director, Sponsored Research Programs, Tufts CSDD; Chairman, CISCRP

AN INTERACTIVE MULTI-STAKEHOLDER ADVISORY PANEL: Increasing Clinical Trial Awareness: Who, What, Where, HOW?  

Co-Moderators:

Kelly McKee, Associate Director, Global Trial Optimization, Clinical Development Execution Organization, Merck & Co., Inc.

Kenneth Getz, MBA, Director, Sponsored Research Programs, Tufts CSDD; Chairman, CISCRP

Panelists:

Joe Kim, Senior Advisor, Clinical Development Innovation, Eli Lilly and Company

Mark Sloan, M.D., Hematology & Medical Oncology, Boston Medical Center

Carley Medosch, MBA, Chronic Illness Advocate

Andrew Lee, M.D., Senior Vice President & Head, Global Clinical Operations, Merck & Co., Inc.


For more details on the Tuesday Opening Plenary Keynote and Wednesday Afternoon Plenary Keynote click here.

Grand Opening Coffee Break in the Exhibit Hall


PREDICTIVE MODELS FOR PATIENT IDENTIFICATION AND DATA-DRIVEN RECRUITMENT

Chairperson’s Remarks

Stewart Rosen, M.D., Vice President, Medcal Affairs, Health Management Solutions, Quintiles

Leveraging EHR Data for Patient Recruitment: Don’t ask, Tell!

Tim McGarty, Global Director, Clinical Innovative Services, Development Strategic Sourcing, Novartis

Innovative Predictive Model for Subject Recruitment Risk in Clinical Trials

Mohanish Anand, Ph.D., Sr. Director and Head, Feasibility Center of Excellence, Development Operations, Pfizer

CO-PRESENTATION: Enabling Strategic and Data Driven Management of Early Development Studies

Timothy Hagerty, Ph.D., Senior Clinical Program Leader, Genentech Research and Early Development Clinical Operations, Genentech

Jennifer Bell, Analytics Lead, Clinical Operations, Genentech

Topic to be Announced

Acurian

Luncheon Presentation

Speaker to be Determined, Praxis


IMPLEMENTING THE NEW REALITY OF DIVERSITY IN TRIALS

Chairperson’s Remarks

Bonnie Feldman, M.D., "All Things Autoimmune" Entrepreneur, DrBonnie 360

Multiculturalism and Your Trials: 3 Reasons to Care and 3 Ways to Rethink Implementation

Lisa Valtierra, Associate Director, Patient Advocacy Relations & Cross Cultural Marketing, Boehringer Ingelheim

Understanding and Implementing the New Reality of Diversity in Clinical Trials

Karen Machelle Brooks, Senior Director, Clinical Operations Therapeutic Area Group Lead, Oncology, Development Operations, Pfizer

CASE STUDY: Operationalizing Diversity Initiatives in Clinical Research

Marisa Rackley, Director, Clinical Research, Global Trial Optimization, Merck

Topic to be Announced

Imperial


Interactive Breakout Discussion Groups

Concurrent breakout discussion groups are interactive, guided discussions hosted by a facilitator or set of co-facilitators to discuss some of the more poignant questions facing the industry. Delegates will join a table of interest to them and become an active part of the discussion at hand. It is an informal, yet informative, format that allows attendees to learn from each other and make some new contacts. To get the most out of this interactive format please come prepared to: share examples from your work, vet some ideas with your peers, be a part of group interrogation and problem solving, and, most importantly, participate in active idea sharing.

View Detailed Interactive Breakout Discussion Groups

Welcome Reception in the Exhibit Hall


VALIDATE RECRUITMENT PLANNING AND OPS BY LISTENING TO MANAGEMENT, THE SITE-SPONSOR-VENDOR, PATIENTS, SOCIAL MEDIA

Chairperson’s Remarks

Mark Summers, President & CEO, ThreeWire, Inc.

CASE STUDY: A Year in Review: Evolving and Validating a Patient Recruitment Department

Diane Montross, Director, Patient Recruitment & Engagement, Shire Pharmaceuticals

The Power of Social Media and Content Marketing

Joseph Kim, MBA, Senior Advisor, Clinical Innovation, Eli Lilly

Partnering for Success: Elements of a Healthy Sponsor/Vendor Relationship

Katherine (Katie) Norton, Associate Director, PRE Lead, Patient Recruitment and Engagement, Shire Pharmaceuticals 

PRA Health SciencesCASE STUDY: Supporting Sites is the Key to Patient Recruitment Success

Gretchen Goller, Senior Director, Patient Access and Retention Services (PARS), PRA International 



ENROLLMENT PLANNING OPTIMIZATION FOR TARGETED POPULATIONS AND PoC TRIALS

Chairperson’s Remarks

Aaron Fleishman, Technology and Product Innovation, BBK Worldwide

Narrowing Enrollment in Trial Planning

Michelle Everill-Flinders, Director, Feasibility Center of Excellence, Pfizer

CASE STUDY: Progression from an Undeveloped Process to Advanced Enrollment Modeling to Support Forecasting of Proof of Concept (PoC) Trials

Sameer Tandon, Clinical Trial Intelligence Manager, CS&I, Novartis Pharmaceuticals Corporation

UBCBRIDGING LUNCHEON PRESENTATION: Harnessing Real-Time Data to Optimize Site and Patient Recruitment

Meghan Winegrad, Managing Director, New Solutions, UBC: An Express Scripts Company, The Lab - Express Scripts Technology and Innovation Center


Stay on and attend Part 2: Engagement and Retention
Keynotes | Monday Short Courses | Speaker Biographies


 


Click on Image

SCOPE 2015 Wrap-Up

Held February 24-26, 2015, in Orlando, Florida, the 6th Annual SCOPE Summit gathered more than 900 industry leaders, an attendance increase of 30% from 2014, for three stimulating days of in-depth discussions covering important issues in clinical trial planning and management. With 12 different conference tracks, a Clinical Informatics News Best Practices Awards and three plenary keynote sessions, SCOPE offered advances and innovative solutions in all aspects of clinical trial management and operations, including Data Integration, Feasibility, Site Selection and Management, Patient Engagement, Recruitment and Retention, Mobile Tech, Project Management, Forecasting, Quality (QbD) in Trial Conduct, Risk-Based Monitoring, Post-Marketing Studies, and Pharmacovigilance. The impressive executive audience at SCOPE came together for invaluable networking opportunities with more than 70% of the attendees titled as Executives from leading Pharma (24%), CRO (31%), and Biotech companies (20%). Industry leaders and key decision makers representing 13 different countries and more than 360 unique organizations shared case studies, collaborated on best practices and provided unique perspectives on poignant issues that the field currently faces.

For Further Information

For questions or suggestions about the meeting, please contact:

Micah Lieberman
Executive Director, Conferences
Cambridge Healthtech Institute (CHI)
T: (+1) 541.482.4709
E: mlieberman@healthtech.com

For partnering and sponsorship information, please contact:

Ilana Quigley
Manager, Business Development
Cambridge Healthtech Institute (CHI)
T: (+1) 781.972.5457
E: iquigley@healthtech.com

For media and association partnerships, please contact:

Rich Handy
Senior Director, Marketing
Cambridge Healthtech Institute (CHI)
T: (+1) 781.972.5456
E: rhandy@healthtech.com

Japan-Flag Korea-Flag China-Simplified-Flag China-Traditional-Flag  



Preliminary Agenda Available!


  Scope CAG 2016

 

> Premier Sponsors

 BBK

 ClinicalInk

Drug Dev

 IMS Health  

PRA Health Sciences

QUINTILES

> View All Sponsors

> View Media Partners

> View Attendee List

> Attendee Profile